724 J. Agric. Food Chem., Vol. 55, No. 3, 2007
Penndorf et al.
B for 10 min, 0% to 10% solvent B in 5 min, 10% to 20% solvent B
in 30 min, 20% to 80% solvent B in 5 min, 80% solvent B for 5 min,
80% to 0% solvent B in 5 min, 0% solvent B for 10 min. The detection
wavelength was 280 nm.
For analysis of FM-Val and furosine, the HPLC system was as above,
but a RP-8 column “furosine dedicated” (Alltech, Unterhaching,
Germany) was used. A linear binary gradient was applied with water
containing 0.4% acetic acid (solvent A) and water containing 0.4%
acetic acid and 0.27% KCL (solvent B). The gradient was as follows:
0
% solvent B for 13.5 min, 0% to 50% solvent B in 7 min, 50% solvent
B for 1.5 min, 50% to 0% solvent B in 1 min, 0% solvent B for 9 min
3). The injection volume was 50 µL, the flow was 1.1 mL/min, and
(
the temperature was set at 34 °C.
For quantification of FMAAs, an external standard of furosine
(Neosystems, Strasbourg, France) was used.
LC-ESI-TOF-MS for Identification of FMAAs. An Agilent 1100
series HPLC system (Agilent Technologies, Palo Alto, USA) consisting
of a high-pressure gradient pump system, column oven, automatic
injector, and diode array detector was coupled to a PerSeptive
Biosystems Mariner time-of-flight mass spectrometer (TOF-MS)
equipped with an electrospray ionization source (ESI) working in the
positive mode (Applied Biosystems, Stafford, USA). RP-HPLC was
performed as described above for the quantification of FM-Val, FM-
Leu, and FM-Ile. MS conditions were as follows: quadrupole RF
voltage 799.80, nozzle temperature 140.01 °C, reflector potential
1
549.99, detector voltage 2299.99, first mass 100, last mass 700.
Preparation and Analysis of Reference Samples. 2 mmol of each
amino acid and peptide (ꢀ-N-acetyllysine, R-N-acetyllysine, alanine,
valine, leucine, isoleucine, isoleucinylglycin, and isoleucinylglycyl-
glycin, respectively; all from Merck, Darmstadt, Germany; peptides
from Bachem, Bubendorf, Switzerland) and 4 mmol of lactose
monohydrate were dissolved in a mixture of 11 mL of methanol and 9
mL of DMSO and were heated at 90 °C for up to 8 h under reflux.
Solvents were removed under vacuum. The dried residues were
dissolved in 20 mL of distilled water. After membrane filtration (0.45
µm), these solutions were used as reference samples containing the
original amino acid plus the corresponding Amadori products (“lactu-
losyl amino acid”, AP-solution). To obtain samples containing the
corresponding FMAAs, 700 µL of each AP-solution was hydrolyzed
with 1380 µL of 12 N HCL in screw-cap test tubes for 23 h at 110 °C.
The complete hydrolyzates were centrifugated (10 000 rpm, 20 min),
and the supernatant was dried under vacuum. The dry residues were
dissolved in 500 µL of 0.2 N hydrochloric acid. After membrane
filtration, these solutions were used as reference samples containing
FMAAs (FMAA solution). 10 µL of each AP- or FMAA-solution,
respectively, was analyzed using RP-HPLC with chemiluminescent
nitrogen detector (CLND). For this, an Agilent 1100 series HPLC
system (Agilent Technologies, Palo Alto, USA) consisting of a high-
pressure gradient pump system, column oven, automatic injector, and
UV-detector was used in combination with a nitrogen-sensitive detector
Antek 8060 (Baumel, Houston, Texas). A RP-18 column (Eurospher
Figure 1. Structures of determined FMAAs (A−F).
In the present study, we address the question whether early
Maillard reactions occurring at the N-termini of peptides are of
importance in foods such as hypoallergenic formulas, which
contain a multiplicity of peptides from hydrolyzed whey proteins
or casein. Selected N-(2-furoylmethyl) amino acids, which are
formed from Amadori products of N-terminal amino acids
during acid hydrolysis (Figure 1), were analyzed by RP-HPLC
with UV-detection in comparison to reference samples prepared
from amino acids and lactose.
EXPERIMENTAL PROCEDURES
Preparation of Samples for Chromatographic Analysis. Seven
samples of hypoallergenic infant formulas (peptide-containing) and four
samples of conventional infant formulas (intact protein-containing) were
obtained from local retail stores. Four human milk samples were
obtained from healthy volunteers. Of the infant formulas, 100 mg was
hydrolyzed with 1.2 mL of 7.95 N hydrochloric acid in screw-cap test
tubes at 110 °C for 23 h. Of the human milk samples, 2.0 mL was
hydrolyzed with 3.9 mL of 37% hydrochloric acid under the same
conditions. After cooling to room temperature, hydrolyzates were
centrifugated (10 000 rpm, 15 min), and the supernatant was dried under
vacuum. The dry residues were dissolved in 500 µL of 0.2 N
hydrochloric acid. After membrane filtration (0.2 µm), 50 µL was
subjected to LC-ESI-TOF-MS or into the RP-HPLC with UV- or
CLND-detection, respectively.
1
00-C18 column, 5 µm, 3 mm × 250 mm, Knauer, Berlin, Germany)
was used at a flow rate of 0.2 mL/min. Gradient elution was performed,
using water (solvent A) and methanol (solvent B), each containing 2%
of formic acid. The following gradients were applied for analyzing the
AP-solutions: alanine (0% to 10% solvent B in 25 min, 30 °C), R-N-
acetyllysine and ꢀ-N-acetyllysine (0% to 10% solvent B in 25 min,
5
0 °C), valine (0% to 15% solvent B in 25 min, 50 °C), leucine and
isoleucine (0% to 20% solvent B in 25 min, 50 °C). The following
gradients were applied for analyzing the FMAA-solutions: FM-Ala
RP-HPLC with UV-Detection for Quantification of FMAAs in
Acid Hydrolysates. For analysis of FM-Val, FM-Leu, and FM-Ile, an
HPLC system consisting of a pump K1001, a gradient mixing system,
a detector K-2501, a column oven, and an automatic injector Marathon
(0% to 10% solvent B in 25 min, 50 °C), R-FM-Lys/furosine (5% to
2
0% solvent B in 30 min, 50 °C), FM-Val (5% to 40% solvent B in 30
(
all from Knauer, Berlin, Germany) was used. The column was a
min, 50 °C), FM-Leu and FM-Ile (5% to 50% solvent B in 30 min,
50 °C). A solution of caffeine (1 mg/mL; Fluka, Buchs, Switzerland)
was used for external calibration. The concentrations of APs and
corresponding FMAAs in the sample solutions were calculated using
the theoretical nitrogen content of the corresponding compound. The
identity of FMAAs and amino acids was verified by LC-ESI-TOF-MS
(system described above).
Eurospher 100-C18 column (5 µm, 4.6 mm × 250 mm, Knauer, Berlin,
Germany) protected by a guard column (8 × 5 mm) containing the
same material. The injection volume was 50 µL, the flow rate was
0
.7 mL/min, and the temperature was set at 25 °C. A gradient was
applied with water (solvent A) and methanol (solvent B), each
containing 2% formic acid. The gradient was as follows: 0% solvent